A process for producing crystalline form I of cabergoline, which process comprises crystallization of the desired form from a toluene/diethyl ether mixture comprising raw cabergoline, followed by recovery and drying of the resulting crystals. A new solvate form V of cabergoline, useful as an intermediate, is also provided.

 
Web www.patentalert.com

< Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof

< Substituted arylamides as IP antagonists

> Process for improving sucralose purity and yield

> Substituted cyclohexane derivatives

~ 00213